Evidence map›Paper›PMID 39693143›Full record

ArticleeLife2024

Dipasree Hajra, Raju S Rajmani, Ayushi Devendrasingh Chaudhary, Shashi Kumar Gupta, Dipshikha Chakravortty

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Frontiers in neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dipasree HajraDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.ORCID https://orcid.org/0000-0002-4970-8638
Raju S RajmaniCentre of Infectious Disease Research, Indian Institute of Science, Bangalore, India.
Ayushi Devendrasingh ChaudharyPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Shashi Kumar GuptaPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Dipshikha ChakravorttyDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.ORCID https://orcid.org/0000-0002-7838-5145

Funding

Council of Scientific and Industrial Research, India SPM-07/079(0293)/2019-EMR-I (CSIR Shyama Prasad Mukherjee Fellowship)Department of Atomic Energy, Government of India DAE00195Department of Biotechnology, Ministry of Science and Technology, India BT/RLF/re-entry/14/2019Department of Biotechnology, Ministry of Science & Technology, India DBT-IISC
6 · The paper itself

Abstract

Sirtuins are the major players in host immunometabolic regulation. However, the role of sirtuins in the modulation of the immune metabolism pertaining to salmonellosis is largely unknown. Here, our investigation focussed on the role of two important sirtuins, SIRT1 and SIRT3, shedding light on their impact on intracellular

Indexed as

MacrophagesSalmonella typhimuriumSirtuin 1Sirtuin 3AnimalsFemaleGlycolysisHost-Pathogen InteractionsHypoxia-Inducible Factor 1, alpha SubunitMiceMice, Inbred C57BLSalmonella InfectionsHypoxia-Inducible Factor 1, alpha SubunitSirt1 protein, mouseSirt3 protein, mouseSirtuin 1Sirtuin 3bacterial disseminationimmune regulationinfectious diseasemetabolic shiftmicrobiologySalmonella enterica serovar TyphimuriumSalmonella metabolismSIRT1SIRT3

Identifiers

PMID39693143
PMCPMC11655064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.